DARE-HPV — Topline data
in 2027
We currently expect to report topline data from the study in 2027.Source filing
DARE biotech catalysts & pipeline
DARE BIOSCIENCE INC · Data as of 2026-09-08
Upcoming catalysts
Ovaprene — Topline data
in 2027
We currently expect to proceed to amend the protocol to eliminate the 250 completer expectation and to enroll sufficient women in 2026 to achieve at least 2,500 menstrual cycles of exposure in 2027, supporting a top line data announcement in 2027.Source filing